Why the study?
What are the long-term outcomes of surgical treatment for benign and malignant intracardiac tumors?
What are the long-term outcomes of surgical treatment for benign and malignant intracardiac tumors?
Surgical resection of benign intracardiac tumors provides excellent long-term outcomes, whereas malignant tumors have a poor long-term prognosis despite initial symptomatic relief.
Supports resection for benign intracardiac tumors; leaves open effective long-term strategies for malignant tumors despite initial benefits.
Twenty-five cases of intracardiac tumors were operated upon from 1975 through 1994. Twenty-four operative survivors were followed up. The follow-up period ranged from 2 months to 19 years with an average of 8 years. The histological diagnoses of the tumors were as follows: benign tumors 21 (myxoma 20, leiomyoma 1) and malignant tumors 4 (sarcoma 3, carcinoma 1). In 21 cases, tumors had cardiac origins, while there were four intracardiac tumors which had originated in other organs and extended transvenously to the intracardiac cavity (leiomyoma 1, sarcoma 2, carcinoma 1). The results of surgical treatment of intracardiac benign tumors were satisfactory, regardless of their origins and multiplicity, both in the short-term and in the long-term. On the other hand, the long term results for malignant intracardiac tumors were extremely poor, although their excision or resection had a beneficial effect on the hemodynamics in patients with congestive heart failure or cardiogenic shock.
No takes yet. Share an insight, caveat, or question.
Kotsuka et al. (1995) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: